Morange PE - Search Results

1

C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies.

Buil A, Trégouët DA, Souto JC, Saut N, Germain M, Rotival M, Tiret L, Cambien F, Lathrop M, Zeller T, Alessi MC, Rodriguez de Cordoba S, Münzel T, Wild P, Fontcuberta J, Gagnon F, Emmerich J, Almasy L, Blankenberg S, Soria JM, Morange PE. Buil A, et al. Among authors: morange pe. Blood. 2010 Jun 10;115(23):4644-50. doi: 10.1182/blood-2010-01-263038. Epub 2010 Mar 8. Blood. 2010. PMID: 20212171 Free PMC article.

2

Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease.

Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Alessi MC, et al. Diabetes. 1997 May;46(5):860-7. doi: 10.2337/diab.46.5.860. Diabetes. 1997. PMID: 9133556

3

Fibrinogen, obesity and insulin resistance.

Juhan-Vague I, Morange P, Renucci JF, Alessi MC. Juhan-Vague I, et al. Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S25-8. Blood Coagul Fibrinolysis. 1999. PMID: 10070814 Review. No abstract available.

4

The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers.

Morange PE, Henry M, Tregouët D, Granel B, Aillaud MF, Alessi MC, Juhan-Vague I. Morange PE, et al. Arterioscler Thromb Vasc Biol. 2000 May;20(5):1387-91. doi: 10.1161/01.atv.20.5.1387. Arterioscler Thromb Vasc Biol. 2000. PMID: 10807758

5

Plasma TAFI antigen variations in healthy subjects.

Chetaille P, Alessi MC, Kouassi D, Morange PE, Juhan-Vague I. Chetaille P, et al. Among authors: morange pe. Thromb Haemost. 2000 Jun;83(6):902-5. Thromb Haemost. 2000. PMID: 10896246

6

Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.

Juhan-Vague I, Alessi MC, Morange PE. Juhan-Vague I, et al. Among authors: morange pe. Ann Med. 2000 Dec;32 Suppl 1:78-84. Ann Med. 2000. PMID: 11209987 Review.

7

Fat cell function and fibrinolysis.

Alessi MC, Morange P, Juhan-Vague I. Alessi MC, et al. Horm Metab Res. 2000 Nov-Dec;32(11-12):504-8. doi: 10.1055/s-2007-978677. Horm Metab Res. 2000. PMID: 11246816 Review.

8

Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled.

Henry M, Aubert H, Morange PE, Nanni I, Alessi MC, Tiret L, Juhan-Vague I. Henry M, et al. Among authors: morange pe. Blood. 2001 Apr 1;97(7):2053-8. doi: 10.1182/blood.v97.7.2053. Blood. 2001. PMID: 11264171 Free article.

9

Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms.

Trégouet DA, Aubert H, Henry M, Morange P, Visvikis S, Juhan-Vague I, Tiret L. Trégouet DA, et al. Hum Genet. 2001 Aug;109(2):191-7. doi: 10.1007/s004390100558. Hum Genet. 2001. PMID: 11511925

10

TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study.

Morange PE, Tiret L, Saut N, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Cambien F, Juhan-Vague I; PRIME Study Group. Morange PE, et al. Eur J Hum Genet. 2004 Dec;12(12):1041-9. doi: 10.1038/sj.ejhg.5201277. Eur J Hum Genet. 2004. PMID: 15367917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

292 results

Search Page